塩野義製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/06/26 | 6,270 | 6,293 | 6,225 | 6,251 | +27 | +0.4% | 1,614,500 |
| 2024/06/25 | 6,149 | 6,224 | 6,117 | 6,224 | +100 | +1.6% | 1,514,000 |
| 2024/06/24 | 6,012 | 6,128 | 5,980 | 6,124 | +116 | +1.9% | 1,472,100 |
| 2024/06/21 | 6,066 | 6,085 | 5,998 | 6,008 | -118 | -1.9% | 3,205,600 |
| 2024/06/20 | 6,078 | 6,146 | 6,065 | 6,126 | +58 | +1% | 1,065,200 |
| 2024/06/19 | 6,080 | 6,104 | 6,051 | 6,068 | -29 | -0.5% | 1,071,300 |
| 2024/06/18 | 6,154 | 6,169 | 6,072 | 6,097 | -50 | -0.8% | 1,407,800 |
| 2024/06/17 | 6,120 | 6,148 | 6,044 | 6,147 | +62 | +1% | 1,423,300 |
| 2024/06/14 | 6,000 | 6,117 | 6,000 | 6,085 | -9 | -0.1% | 2,187,100 |
| 2024/06/13 | 6,112 | 6,139 | 6,010 | 6,094 | -3 | ±0% | 1,722,200 |
| 2024/06/12 | 6,059 | 6,118 | 5,985 | 6,097 | -3 | ±0% | 2,892,300 |
| 2024/06/11 | 6,201 | 6,228 | 6,100 | 6,100 | -186 | -3% | 3,948,000 |
| 2024/06/10 | 6,315 | 6,319 | 6,245 | 6,286 | -15 | -0.2% | 3,027,200 |
| 2024/06/07 | 6,435 | 6,480 | 6,106 | 6,301 | -934 | -12.9% | 9,368,200 |
| 2024/06/06 | 7,208 | 7,314 | 7,188 | 7,235 | +27 | +0.4% | 968,900 |
| 2024/06/05 | 7,232 | 7,244 | 7,158 | 7,208 | ±0 | ±0% | 731,200 |
| 2024/06/04 | 7,040 | 7,208 | 7,040 | 7,208 | +90 | +1.3% | 780,700 |
| 2024/06/03 | 7,081 | 7,158 | 7,075 | 7,118 | +78 | +1.1% | 859,700 |
| 2024/05/31 | 7,046 | 7,134 | 7,022 | 7,040 | +64 | +0.9% | 4,631,200 |
| 2024/05/30 | 6,952 | 6,976 | 6,890 | 6,976 | -14 | -0.2% | 1,636,400 |
| 2024/05/29 | 6,967 | 7,003 | 6,934 | 6,990 | -7 | -0.1% | 888,500 |
| 2024/05/28 | 6,948 | 7,014 | 6,922 | 6,997 | +76 | +1.1% | 798,900 |
| 2024/05/27 | 6,901 | 6,929 | 6,867 | 6,921 | ±0 | ±0% | 731,700 |
| 2024/05/24 | 6,839 | 6,921 | 6,832 | 6,921 | +43 | +0.6% | 938,400 |
| 2024/05/23 | 6,830 | 6,899 | 6,780 | 6,878 | +104 | +1.5% | 1,408,700 |
| 2024/05/22 | 6,987 | 6,999 | 6,729 | 6,774 | -261 | -3.7% | 1,724,100 |
| 2024/05/21 | 7,086 | 7,120 | 7,030 | 7,035 | -109 | -1.5% | 1,015,800 |
| 2024/05/20 | 7,130 | 7,258 | 7,081 | 7,144 | +15 | +0.2% | 914,500 |
| 2024/05/17 | 7,138 | 7,150 | 7,084 | 7,129 | -82 | -1.1% | 725,400 |
| 2024/05/16 | 7,237 | 7,305 | 7,187 | 7,211 | -43 | -0.6% | 742,400 |
| 2024/05/15 | 7,333 | 7,423 | 7,214 | 7,254 | -66 | -0.9% | 1,034,300 |
| 2024/05/14 | 7,343 | 7,490 | 7,221 | 7,320 | -309 | -4.1% | 1,332,800 |
| 2024/05/13 | 7,471 | 7,650 | 7,387 | 7,629 | +140 | +1.9% | 995,100 |
| 2024/05/10 | 7,511 | 7,555 | 7,452 | 7,489 | ±0 | ±0% | 541,800 |
| 2024/05/09 | 7,461 | 7,533 | 7,445 | 7,489 | +92 | +1.2% | 748,100 |
| 2024/05/08 | 7,480 | 7,486 | 7,365 | 7,397 | -17 | -0.2% | 639,700 |
| 2024/05/07 | 7,345 | 7,419 | 7,316 | 7,414 | +70 | +1% | 736,900 |
| 2024/05/02 | 7,370 | 7,408 | 7,323 | 7,344 | -45 | -0.6% | 409,000 |
| 2024/05/01 | 7,328 | 7,425 | 7,315 | 7,389 | +15 | +0.2% | 309,800 |
| 2024/04/30 | 7,440 | 7,440 | 7,313 | 7,374 | +68 | +0.9% | 643,900 |
| 2024/04/26 | 7,168 | 7,337 | 7,128 | 7,306 | +158 | +2.2% | 778,400 |
| 2024/04/25 | 7,342 | 7,343 | 7,131 | 7,148 | -195 | -2.7% | 647,900 |
| 2024/04/24 | 7,381 | 7,393 | 7,286 | 7,343 | ±0 | ±0% | 653,400 |
| 2024/04/23 | 7,264 | 7,348 | 7,257 | 7,343 | +76 | +1% | 579,900 |
| 2024/04/22 | 7,209 | 7,280 | 7,139 | 7,267 | +153 | +2.2% | 626,400 |
| 2024/04/19 | 7,136 | 7,183 | 7,062 | 7,114 | -32 | -0.4% | 741,500 |
| 2024/04/18 | 7,101 | 7,201 | 7,080 | 7,146 | +46 | +0.6% | 614,900 |
| 2024/04/17 | 7,150 | 7,173 | 7,085 | 7,100 | -126 | -1.7% | 618,300 |
| 2024/04/16 | 7,171 | 7,229 | 7,151 | 7,226 | -11 | -0.2% | 659,900 |
| 2024/04/15 | 7,225 | 7,259 | 7,171 | 7,237 | -99 | -1.3% | 670,900 |
101～
150
件表示中 / 3585件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 塩野義 | 205,900円 | +5.7% | +3.9% | 2.78% | 10.24倍 | 1.35倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| 大塚ＨＤ | 895,200円 | +14.4% | +120.8% | 1.34% | 20.09倍 | 1.84倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| アステラス薬 | 157,200円 | +12.2% | +180.3% | 4.71% | 56.28倍 | 1.84倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| エーザイ | 461,900円 | +1.7% | -2.9% | 3.46% | 30.30倍 | 1.59倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| 協和キリン | 254,500円 | +11.3% | -5.4% | 2.28% | 19.59倍 | 1.54倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
市場注目の銘柄
チャート関連のコラム
